RxDoctor Payments Data

Amanda Nelson

Physician Assistant · Long Beach, CANPI 1932509072

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $37,125 of the $45,453 with a category attached, or 81.7%. AbbVie accounts for 95.1% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2022 at $26,005 and has fallen 98.7% since, to $342 in 2025. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,453in general payments, 2019–2025

Across 203 payments — averaging $223.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$43K
  • Johnson & Johnson$695
  • Ironshore Pharmaceuticals Inc.$562
  • Neurocrine Biosciences, Inc.$134
  • Teva Pharmaceuticals USA, Inc.$127
  • Bausch Health US, LLC$100
  • plus $594 from 17 others

What the payments were for

  • Speaking & faculty fees$37,12582%
  • Travel & lodging$4,65310%
  • Food & beverage$3,6758%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,453 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine12$163,530
Wellbutrin XlBupropion Hcl12$55,757
AplenzinBupropion Hbr12$31,381
VyvanseLisdexamfetamine Dimesylate15$7,116
Lisdexamfetamine Dimesylate15$3,486
Aripiprazole37$2,933
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine21$2,700
Duloxetine Hcl72$1,766
Vilazodone Hcl23$1,568
Quetiapine Fumarate48$1,137
Bupropion XlBupropion Hcl51$1,026
Escitalopram Oxalate51$872
Trazodone Hcl59$560
Gabapentin44$555
Lurasidone Hcl17$541

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$127$163,53012 claims
Bausch Health US, LLCAplenzin$100$31,38112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →